Han Lee
Vermogen: - $ op 31-07-2026
Vermogen: - $ op 31-07-2026
Han Lee is an Independent Director at Century Therapeutics, Inc. since 2025.
Formerly, Dr. Lee was President & Chief Financial Officer at ImmPACT Bio USA, Inc. from 2023 to 2024.
Education includes an MBA and a doctorate from Yale University, and an undergraduate degree from the University of California, Berkeley.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 11-06-2026 | 0 ( -.--% ) | - $ | 31-07-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| CENTURY THERAPEUTICS, INC. | Directeur/Bestuurslid | 09-12-2025 |
| Bedrijven | Functie | Einde |
|---|---|---|
Immpact Bio USA, Inc.
Immpact Bio USA, Inc. BiotechnologyHealth Technology Develops cell therapy for treating cancer | Financieel Directeur/CFO | 01-10-2024 |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 4 |
|---|---|
Yale University
Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California, Berkeley
University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Century Therapeutics, Inc.
Century Therapeutics, Inc. BiotechnologyHealth Technology Develops novel allogeneic living drugs for oncology that overcome the limitations of first-generation cell therapies | Health Technology |
Immpact Bio USA, Inc.
Immpact Bio USA, Inc. BiotechnologyHealth Technology Develops cell therapy for treating cancer | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau